0.00
price down icon100.00%   -0.242
after-market アフターアワーズ: .01 0.01 +
loading
前日終値:
$0.242
開ける:
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額:
$N/A
収益:
-
当期純損益:
$-13.24M
株価収益率:
0.00
EPS:
-8.83
ネットキャッシュフロー:
$-16.85M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-97.91%
1年 パフォーマンス:
-99.74%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$0.00
$0.00
52週間の値動き範囲:
Value
$0.00
$0.2869

Virpax Pharmaceuticals Inc Stock (VRPX) Company Profile

Name
名前
Virpax Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
VRPX's Discussions on Twitter

VRPX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VRPX
Virpax Pharmaceuticals Inc
0.00 0 0 -13.24M -16.85M -8.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Virpax Pharmaceuticals Inc (VRPX) 最新ニュース

pulisher
Jul 18, 2025

Promising Nanotechnology Stocks To Watch Now – July 16th - Defense World

Jul 18, 2025
pulisher
Jul 16, 2025

Promising Nanotechnology Stocks To Watch NowJuly 16th - MarketBeat

Jul 16, 2025
pulisher
Jul 11, 2025

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading Down 2.9% – Should You Sell? - Defense World

Jul 11, 2025
pulisher
Jul 11, 2025

Promising Nanotechnology Stocks To Add to Your Watchlist – July 9th - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

Promising Nanotechnology Stocks To Add to Your WatchlistJuly 9th - MarketBeat

Jul 09, 2025
pulisher
Jul 09, 2025

Nanotechnology Stocks To Watch Today – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 05, 2025

Nanotechnology Stocks To Research – July 3rd - Defense World

Jul 05, 2025
pulisher
Jun 18, 2025

Best Nanotechnology Stocks To Add to Your WatchlistJune 16th - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Top Nanotechnology Stocks Worth WatchingJune 17th - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Best Nanotechnology Stocks To Keep An Eye OnJune 15th - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Nanotechnology Stocks To Watch NowJune 14th - MarketBeat

Jun 17, 2025
pulisher
Jun 11, 2025

Promising Nanotechnology Stocks To ResearchJune 11th - MarketBeat

Jun 11, 2025
pulisher
Jun 11, 2025

Nanotechnology Stocks To ResearchJune 8th - MarketBeat

Jun 11, 2025
pulisher
Jun 09, 2025

Nanotechnology Stocks To Follow NowJune 9th - MarketBeat

Jun 09, 2025
pulisher
Jun 02, 2025

Best Nanotechnology Stocks To Follow Today – May 31st - Defense World

Jun 02, 2025
pulisher
May 28, 2025

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading 4.4% Higher – Still a Buy? - Defense World

May 28, 2025
pulisher
May 15, 2025

Virpax Pharmaceuticals appoints new independent director - MSN

May 15, 2025
pulisher
May 13, 2025

Virpax and Nanomerics Enter Technology License Agreement for Developing A Product for PTSD Treatment - StatNano

May 13, 2025
pulisher
May 09, 2025

Promising Nanotechnology Stocks To Watch Now – May 7th - The AM Reporter

May 09, 2025
pulisher
May 06, 2025

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading Up 5.5% – Here’s What Happened - Defense World

May 06, 2025
pulisher
May 02, 2025

Virpax(R) Pharmaceuticals Announces Appointment of Michèle C. Linde, EVP, General Counsel - ACCESS Newswire

May 02, 2025
pulisher
Apr 15, 2025

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Sees Large Increase in Short Interest - Defense World

Apr 15, 2025
pulisher
Apr 09, 2025

Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology Conference - MSN

Apr 09, 2025
pulisher
Apr 04, 2025

VRPX stock plunges to 52-week low, touches $1.07 - Investing.com Australia

Apr 04, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals to be delisted from Nasdaq By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals to be delisted from Nasdaq - Investing.com

Apr 03, 2025
pulisher
Mar 22, 2025

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 21, 2025

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split - Investing.com India

Mar 21, 2025
pulisher
Mar 20, 2025

VRPX stock plunges to 52-week low of $0.12 amid market challenges - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals - Business Wire

Mar 20, 2025
pulisher
Mar 19, 2025

Virpax Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

VRPX stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Virpax Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Virpax Pharmaceuticals Announces Reverse Stock Split - Business Wire

Mar 19, 2025
pulisher
Mar 19, 2025

Virpax Reports Positive Results From Dose Range Finding Study of Pain Relief Treatment in Beagle Dogs - MarketScreener

Mar 19, 2025
pulisher
Mar 18, 2025

Virpax receives positive Probudur(TM) results for dose range study -March 18, 2025 at 05:34 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Virpax reports positive results in Probudur dog study By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Virpax reports positive results in Probudur dog study - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Breakthrough: Virpax's 5-Day Pain Drug Passes Critical Safety Test - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Virpax Pharmaceuticals Explores Intranasal mRNA Vaccine Delivery Using MET - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

Virpax Pharmaceuticals stock hits 52-week low at $0.18 By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

Virpax Pharmaceuticals stock hits 52-week low at $0.18 - Investing.com

Mar 11, 2025

Virpax Pharmaceuticals Inc (VRPX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):